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Abstract
Background: Breast cancer is one of the major cancer types
found among Indonesian women. This cancer diagnosis and its
treatment causes perpetual financial burden for the women and
their family. This study aims to identify the correlation between
socio-demographics with financial toxicity among women with
breast cancer in Indonesia. 
Design and methods: This study design was cross-sectional
with 109 respondents of Indonesian breast cancer survivors who
were recruited using consecutive sampling. Quantitative data were
collected with a demographic and a Comprehensive Score for
Financial Toxicity (COST) questionnaires, then analyzed using
Chi-Square test and linear regression method. 
Results: The majority of the women were 18 to 55-years-old
(75.2%), married (91.7%), employed (80.7%), and having moder-
ate income (58.7%). Logistic regression analysis indicates that
survivor’s family as a primary wage earner (p=0.042), low-high
income (p=0.043), and dependents number (p=0.012) are signifi-
cantly associated with financial toxicity. 
Conclusions: The financial toxicity among women with breast
cancer was mainly correlated with the number of survivor’s
dependent and the household income. This study encourage relat-
ed parties to establish socio-economic safety net for women with
breast cancer, including their families.
Introduction
Cancer is an illness that requires high medical costs in its care
and treatment. The type of cancer that mostly affects women in
Indonesia is breast cancer at 42.1% per 100,000 population based
on data from the Ministry of Health of Indonesia.1 Indonesia is a
middle-income country with an emerging economy where most
people are aspiring middle-class, accounting for almost half of the
total population.2 A cancer diagnosis is, therefore, a financial con-
cern for women in Indonesia.
Financial problems and cost concerns are common among
cancer patients. Patients need to adjust their expenses with the
income. However, they faced a high expenditure for cancer care
and treatment, thus it is difficult to have a stable financial condi-
tion. In the United States, cancer is the second most expensive dis-
ease after heart disease, accounting for annual expenses of US$
124 billion in 2010, and increasing to US$ 157 billion in 2020.
The 27% increase came from the cost of consulting and cancer
therapy.3 In China, expenditure per patient with breast cancer is
US$8532 (8234–8831), while the average annual household
income was US$8607.4 In Indonesia, the government, through
BPJS Kesehatan, the Indonesian governing body for Universal
Health Coverage, reported cancer accounted for approximately
US$183 million from the body’s cost coverage in 2018.5 The
increase in cost creates problems for not only the patients and their
families but also doctors, health service facilities, health service
providers, and insurance agency or government financing agen-
cies.3
Despite the healthcare coverage for cancer in Indonesia, an
amount of expense is still spent by the cancer patient’s household
for healthcare and treatment. Out-of-pocket (OOP) expenses such
as transportation expenses, non-medical or treatment modalities
uncovered by BPJS Kesehatan, and other expenses spent to adjust
the lives of the patients with cancer in order to accommodate their
treatment regime puts a burden on their household. The ACTION
Study Group studied that 12 months after a cancer diagnosis, 48%
of patients with cancer in ASEAN experienced financial catastro-
phe.6
The financial adverse effects induced by cancer and its treat-
ment is termed as financial toxicity. Another definition is that
financial toxicity in patients with cancer is the subjective financial
distress and objective financial burden caused by cancer treatment
and its related costs.7 It is a familiar term in the discussion of can-
cer treatment and drug costs. 
Financial toxicity (FT) in patients with cancer is a growing
problem. It is known to be linked with worse mortality. The corre-
lation is theorized to be caused by worse general well-being,
decreased quality of life because of lifestyle changes caused by a
lack of living costs, and non-optimal cancer treatment.8 A pilot
study found that with the high out-of-pocket expenses of cancer,
patients are forced to spend less on their living costs such as food,
clothing, leisure activities/ spending, and to work longer hours to
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balance them.9 Furthermore, it is reported that patients with finan-
cial toxicity were more likely to be noncompliant with medication,
doctor’s visits, and medical tests. Patients with financial toxicity
were also more likely to be less caring for their mental health.10
Financial toxicity was also found to cause a higher risk-taking atti-
tude in patients with cancer in Indonesia.11 
Previous studies have identified several factors to have a vary-
ing degree of influence in financial toxicity experienced by
patients. Factors of the socio-demographic nature, such as level of
income, education level, race, and employment, have positively
affected financial toxicity in patients with cancer.12 While some
themes were consistent in financial toxicity research, varying
results in which factor contributes more to worse financial distress
were reported.13-15
Despite the high number of researches done on breast cancer in
Indonesia, a specific study for financial toxicity experienced by
breast cancer patients in Indonesia numbered low compared to the
high prevalence of cancer. There is a gap in knowledge of what
affects financial toxicity in cancer patients in Indonesia, particular-
ly in the population of breast cancer patients. This study is thus
aimed to identify the correlation of socio-demographic factors with
financial toxicity for women with breast cancer in Indonesia.
Understanding these factors are important in designing future pol-
icy and health intervention which help to increase the breast cancer
survivorship and quality of life. It also expected to define best
approach in preventing financial toxicity in conjunction with par-
ticular social, financial, and cultural disparities of Indonesian
breast cancer survivors.  
Design and methods
This research used a quantitative approach with a cross-sec-
tional research design. The research design was chosen to deter-
mine the factors that can affect financial toxicity in women with
breast cancer. The data collection was conducted for two months,
from early May to the end of July 2020, at a Public Hospital in
Central Jakarta, where the sampling was carried out in the Tumor
Surgery Polyclinic unit and the Oncology Section of its Obstetrics
and Gynecology unit. The sampling used in this study was consec-
utive, and direct sampling was carried out by researchers to
respondents. The inclusion criteria were: 1) women with breast
cancer aged 18 years and older; 2) being hospitalized and or were
undergoing treatment for breast cancer; 3) have undergone surgery,
chemotherapy, radiation, or a combination of the three as treat-
ment. The exclusion criteria were patients with recurring cancer
cases and agreed to participate in this study. A total of 125 women
were assessed for eligibility in this hospital, but 16 were excluded
(10 respondents had recurrent cancer, 5 women refused to partici-
pate, and 1 respondent did not complete the questionnaire).
The data collection tool used is a questionnaire consisting of a
demographic questionnaire and the Comprehensive Score for
Financial Toxicity (COST) questionnaire. The socio-demographic
questionnaire consisted of 13 socio-demographic items. The items
were age, marital status, education level, employment, income,
number of doctor visits, wage earner, cancer stage, type of treat-
ment, clinician’s communication, indirect expenses, and number of
dependents. The COST questionnaire was a questionnaire devel-
oped by de Souza, et al. (2014) to measure financial toxicity in
cancer patients.16 The instrument has been tested for reliability and
validity and has shown excellent internal consistency. The
Cronbach α was 0.92.17 The questionnaire was translated into
Indonesian Language and was put through a pilot test to 54 respon-
dents to measure the translated questionnaire’s reliability and
validity. The translated questionnaire showed internal consistency
with a Cronbach α value of 0.895.
The Comprehensive Score for Financial Toxicity (COST)
questionnaire is a widely used questionnaire in measuring
Financial Toxicity. It consists of 11 statements related to patients’
financial situation during a specific time frame mentioned in the
questionnaire. Each statement was indexed from 1 to 5, with 1 as
“completely disagree” and 5 as “completely agree”. The average of
obtained values was calculated to get an index value representing
respondents’ financial toxicity. The closer the average index value
to 5, the more severe the financial toxicity is.
Data analysis was performed on the data collected from the
fully completed questionnaires. The researchers performed
descriptive statistics (mean, median, SD, frequency, percentage,
minimum, and maximum) to analyze the demographic characteris-
tics. Bivariate and multivariate analyses, namely the Chi-Square
test and linear regression method, were performed to identify the
relationships between the variables. We used SPSS software ver-
sion 22 (SPSS Inc., Chicago, IL, USA) to assist our statistical
works.
This research has received ethical approval with the number:
SK-116/UN2.F12.DI.2.1/ETIK/2020 from the Research Ethics
Committee of the Faculty of Nursing, University of Indonesia.
Prior to data collection, every individual approached as a partici-
pant was informed of the basic information of the study. Those
who agreed to participate in the study were required to fulfill an
informed consent to participate in the study. The identity of the
respondents was kept confidential with the use of numeric coding
to the questionnaires. The respondents were asked to complete the
questionnaire by themselves. The researchers prepared assistance
to complete their questionnaire should there were illiterate respon-
dents. However, all participants were literate.
Results
Of 109 respondents. Most of the women are within the produc-
tive age range (75,2%) and are married. The majority finished high
school or higher education (86,2%) and worked as a housewife.
More than half comes from middle-income households with their
spouses or other family members as the wage earner. Table 1
shows the distribution of each socio-demographic variables.
Financial toxicity was measured with the Comprehensive
Score for Financial Toxicity (COST) questionnaire. The Financial
Toxicity Index median was 3.55 in which indicated that the aver-
age respondents were close to the more severe financial toxicity
(Table 2). 
The socio-demographic characteristics and financial toxicity
were further analyzed with the bivariate test to determine the cor-
relation between the two variables. According to the p-value,
selected items were then analyzed further with linear regression
modeling. The result of the analysis is presented in Table 3. The
factors analyzed with linear regression are the items that in the
bivariate analysis have a p-value <0.25, while those with a p-value
>0.25 will be excluded from modeling. However, if these factors
are substantially important, they can be considered as candidates
for multivariate analysis. According to the bivariate analysis, 10
out of 12 socio-demographic factors were included in multivariate
analysis, including: marital status, education, employment,
income, number of hospital visit, wage earner, cancer stage, type
of treatment, indirect expenses, and number of dependents. 
The results of the multivariate analysis showed that there were
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eight stages of modeling. The eighth stage is the final modeling,
and it is obtained that the p-value in the modeling meets the mod-
eling criteria. Thus, the dominant socio demographic factors that
affect financial toxicity in patients with breast cancer are indirect
expense (p=0.012), wage earner (p=0.042), and income (p=0.043)
(Table 4). Linear regression of index financial toxicity is
3.833+0.355 wage earner + 0.175 income – 0.432 indirect expens-
es (R2 = 14%).
Discussion
This study aimed to examine the correlation between socio-
demographic characteristics and financial toxicity in women with
breast cancer in Indonesia. This study finds that the majority of
respondents have worse financial toxicity (Table 2). Effendy
argued it is no surprise that many cancer patients reported unmet
financial-related need, given the large portion (3/4) of the
Indonesian population was under-insured.18 Since 2014, the
Indonesian government set up the Indonesian national health insur-
ance through the Social Security Administering Body (Badan
Penyelengara Jaminan Sosial, BPJS) Health Program, which cov-
ers cancer therapies.19 While this scheme offers comprehensive
benefits for cancer treatment, despite the exception of some drugs
(e.g., bevacizumab and cetuximab), cancer patients are still heavily
burdened. Even in the Southeast Asian countries with established
universal health coverage such as Malaysia, the patients are still
heavily burdened with Out-of-Pocket (OOP) costs.20
Data analysis in the present study shows that socio-demo-
graphic factors, namely, the wage earner, the income, and the indi-
rect expenses, are correlated with financial toxicity in this study’s
respondents. Lower income are at greater risk of being affected
with worse financial toxicity, while patients as wage earners expe-
rience high financial burdens as a result of cancer care and treat-
ment. This occurs due to reduced physical ability resulting from
cancer treatment, which interferes with their ability to work, result-
ing in less income for both patients and families. The negative eco-
nomic impact on survivors can be exacerbated by reduced income
during care and or recovery and health services related to long-
term care, as investigated in the research conducted by Mady et
al.21 The correlation of low income on financial toxicity is also
supported by Jing et al. and Hoang et al. that found low-income
households have worse financial toxicity compared to those with
high income.14,15 This is an expected phenomenon as higher-
income provide them with more resources and, therefore, more
resilience to cancer diagnosis’s financial impact in general.
Respondents with high financial toxicity are seven times more
likely to delay or avoid treatment due to financial constraints, espe-
cially if they are wage earners. The cancer experience caused a
decrease in physical function and ability, leading to patients quit-
ting their job.22 Pearce et al. similarly found that the wage earner’s
role has a significant, influential factor in financial toxicity
because of the decreased financial ability as a result of quitting
their job. This can also lead to non-compliance in cancer care and
treatment.23
The COVID-19 Pandemic exacerbates the situation. As early
as May 2020, 2.1 Million people in Indonesia become unemployed
due to the pandemic’s economic impact on most industries driving
the country’s economy.24 Many businesses are forced to lay off
their workers or reduce their work time and, as a consequence,
reduce their wages in order to cope with the loss in business related
to the pandemic. The loss of income or prolonged unemployment
due to the pandemic doubled patients’ financial burden with can-
cer. The pandemic has also impacted the delivery of cancer care in
healthcare settings. Strict health protocols, physical distancing,
and lockdowns are being implemented to contain the spread of
COVID-19, thus delaying or disrupting care delivery for patients
with cancer.25 The interruption could prove fatal to patients as it
could lead to worsening conditions in patients. Especially in
patients with more advanced breast cancer, it could lead to a cost-
lier treatment option. More extensive treatment costs and the cost
generated from the treatment’s adverse effect are associated with
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Table 1. Socio-demographic characteristics of respondents
(n=109) .
Factor                                                                    n                 %
Age                                                                                                 
        18-55 years                                                                         82                   75.2
        >55 years                                                                           27                   24.8
Marital status                                                                                                       
        Single                                                                                  6                     5.5
        Married                                                                             100                  91.7
        Divorced                                                                              3                     2.8
Education                                                                                                             
        Diploma/undergraduate                                                 15                   13.8
        Highschool                                                                         69                   63.3
        Primary school                                                                  25                   22.9
Employment                                                                                                         
        Employed                                                                          88                   80.7
        Unemployed                                                                       5                     4.6
        Housewife                                                                          16                   14.7
Income (IDR)                                                                                                      
        High >4.3 mil/month                                                       29                   26.6
        Moderate 2.9–4.3 mil/month                                         64                   58.7
        Low <2.9 mil/month                                                        16                   14.7
Number of hospital visits                                                                                 
        ≤2                                                                                        44                   40.4
        ≥3                                                                                        65                   59.6
Wage earner                                                                                                         
        Myself                                                                                 17                   15.6
        Husband/partner/other family members                   92                   84.4
Cancer stage                                                                                                        
        Stage 0 and 1                                                                      3                     2.8
        Stage 2 and 3                                                                    105                  96.3
        Stage 4                                                                                 1                       9
Type of treatment                                                                                               
        Surgery                                                                               18                   16.5
        Chemotherapy/radiation                                                14                   12.8
        Combination                                                                      77                   70.6
Clinicians’ communication                                                                               
        Yes                                                                                       29                   26.6
        No                                                                                        80                   73.4
Indirect expenses                                                                                              
        Transportation                                                                   2                     1.8
        Transportation and lodging                                             6                     5.5
        Transportation, lodging, and children sickness cost101                92.7
Number of dependents                                                                                     
        <2                                                                                        54                   49.5
        >2                                                                                        55                   50.5
Table 2. Financial toxicity index (n=109).
Factor                         Median               Minimum             Maximum










worse financial toxicity.14,26 In addition to the delay or disruption
in treatment caused by the change in the healthcare system, the
COVID-19 itself posed a great risk as patients with cancer are at a
higher risk of being infected, leading to a higher mortality rate.27
This study also found indirect expenses affected financial tox-
icity experienced by patients with breast cancer. The cancer treat-
ment involved other costs such as transportation, lodging, work-
related productivity losses, other than the medical expenditure. All
participants in this study expressed some level of indirect expendi-
ture, with 92.7% of them showed greater indirect expenditure
spent on transportation, lodging, and the cost of sickness in chil-
dren. A study of Expenditure and financial burden in China sup-
ported this study finding. It is showed that non-medical expendi-
ture added a substantial amount of expenses. The treatment cost
and non-medical expenditure combined presented 77.6% of house-
holds’ unmanageable financial burden.4
The present study has limitations that should be noted and
must be taken with caution. This study results cannot be general-
ized to other settings due to its single-center approach.
Furthermore, our relatively small sample size limits the generaliz-
ability of the study. Further study on a larger scale should be con-
ducted and involves other factors, such as quality of life, that could
help understand the stress associated with the financial burden and
the changes in patients’ quality of life through cancer trajectory.
Conclusions
Most of the women with breast cancer in this study presented
a high level of financial toxicity. Worse financial toxicity is asso-
ciated with socio-demographic factors, namely wage earners,
income, and indirect expenditure. This financial toxicity can nega-
tively impact the well-being and quality of life of cancer patients.
These study findings should encourage the government to provide
a socio-economic safety net for women with breast cancer, includ-
ing their families. The availability of comprehensive services
between nurses, doctors, and the finance department is needed to
help patients manage the objective financial burden and subjective
financial difficulties. Furthermore, as financial toxicity is related to
the quality of life of cancer patients, standardized tools to measure
patients’ financial distress are recommended to be used in patients’
assessment. The assessment should provide data for the nurses to
plan care and prepare to provide them with adequate information
regarding financial support available for them.
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Table 4. Linear regression multivariate analysis.
Stage modeling             Factor Unstandardized coefficient                    Standardized coefficient                  t            p
                                                                                                            
                                                                                 B                      SE                                                                                                         
Final modeling                       Constant                                    3.833                        0.587                                                                                                               6.534         0.001
                                              Wage earner                                 0.355                        0.173                                                             0.197                                          2.054         0.042
                                                   Income                                      0.175                        0.086                                                             0.197                                          2.045         0.043
                                         Indirect expenses                           -0.432                       0.170                                                            -0.229                                        -2.546        0.012
Dependent variable: financial toxicity.
Table 3. Bivariate analysis (n=109).
Factors                                 Median    Minimum     Maximum    p
Age                                                                                                                                0. 583
         18-55 y.o.                                                  3.64                    1.00                          5.00                 
         >55 y.o.                                                     3.55                    1.09                          4.91                 
Marital status                                                                                                                                 0.151*
         Single                                                       3.55                    3.09                          3.55                 
         Married                                                   3.64                    1.00                          5.00                 
         Divorced                                                  3.37                    2.55                          3.91                 
Education                                                                                                                                        0.138*
         Diploma/undergraduate                       3.55                    1.64                          5.00                 
         Highschool                                              3.73                    1.00                          5.00                 
         Primary school                                       3.55                    2.00                          4.27                 
Employment                                                                                                                                    0.026*
         Employed                                                3.50                    1.64                          5.00                 
         Unemployed                                              4                       3.45                          4.36                 
         Housewife/ not working                       3.64                    1.00                          5.00                 
Income (IDR)                                                                                                                                 0.013*
         High >4.3 mil/month                             3.50                    1.64                          4.55                 
         Moderate 2.9-4.3 mil/month                3.73                    3.00                          5.00                 
         Low <2.9 mil/month                              3.55                    1.00                          4.36                 
Number of visits                                                                                                                            0.056*
         ≤2                                                              3.55                    1.00                          5.00                 
         ≥3                                                              3.64                    2.00                          5.00                 
Wage earner                                                                                                                                   0.019*
         Myself                                                       3.45                    1.00                          5.00                 
         Husband/partner/other family member                      3.64                          1.09             5.00
         Cancer stage                                                                                                                         0.070*
         Stage 0 and 1                                           3.18                    2.55                          3.55                 
         Stage 2 and 3                                           3.64                    1.00                          5.00                 
         Stage 4                                                      3.00                    2.00                          5.00                 
Type of treatment                                                                                                                          0.009*
         Surgery                                                     3.50                    1.64                          4.36                 
         Chemotherapy/radiation                      3.55                    2.64                          4.18                 
         Combination                                           3.73                    1.00                          5.00                 
Clinicians communication                                                                                                            0.756
         Yes                                                            3.73                    1.09                          4.91                 
         No                                                             3.55                    1.00                          5.00                 
Indirect expenses                                                                                                                         0.036*
         Transportation                                       3.55                    1.00                          5.00                 
         Transportation and Lodging                4.09                    3.45                          4.55                 
         Transportation, lodging, and 
         children sickness cost                         4.64                    4.27                          5.00                 
Number of dependents                                                                                                                0.013*
         <2                                                              3.55                    1.09                          4.55                 
         >2                                                              3.73                    1.00                          5.00              
*p<0.25 (entered multivariate analysis).
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